Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study
Bakish, David, MD, Bose, Anjana, PhD, Gommoll, Carl, MS, Chen, Changzheng, PhD, Nunez, Rene, MD, Greenberg, William M, MD, Liebowitz, Michael, MD, Khan, Arif, MD
Published in Journal of psychiatry & neuroscience (2014)
Published in Journal of psychiatry & neuroscience (2014)
Get full text
Journal Article
Levomilnacipran Pharmacokinetics in Healthy Volunteers Versus Patients with Major Depressive Disorder and Implications for Norepinephrine and Serotonin Reuptake Inhibition
Chen, Laishun, PhD, Greenberg, William M., MD, Gommoll, Carl, MS, O’Connor, Joann, PhD, Zukin, Stephen R., MD, Periclou, Antonia, PhD, Ghahramani, Parviz, PhD
Published in Clinical therapeutics (01.09.2015)
Published in Clinical therapeutics (01.09.2015)
Get full text
Journal Article
Safety and tolerability of cariprazine in the long-term treatment of schizophrenia: results from a 48-week, single-arm, open-label extension study
Durgam, Suresh, Greenberg, William M., Li, Dayong, Lu, Kaifeng, Laszlovszky, Istvan, Nemeth, Gyorgy, Migliore, Raffaele, Volk, Stephen
Published in Psychopharmacology (01.01.2017)
Published in Psychopharmacology (01.01.2017)
Get full text
Journal Article
Cariprazine in the treatment of acute mania in bipolar I disorder: A double-blind, placebo-controlled, Phase III trial
Sachs, Gary S, Greenberg, William M, Starace, Anju, Lu, Kaifeng, Ruth, Adam, Laszlovszky, István, Németh, György, Durgam, Suresh
Published in Journal of affective disorders (15.03.2015)
Published in Journal of affective disorders (15.03.2015)
Get full text
Journal Article
Efficacy and safety of levomilnacipran sustained release 40 mg, 80 mg, or 120 mg in major depressive disorder: a phase 3, randomized, double-blind, placebo-controlled study
Asnis, Gregory M, Bose, Anjana, Gommoll, Carl P, Chen, Changzheng, Greenberg, William M
Published in The journal of clinical psychiatry (01.03.2013)
Published in The journal of clinical psychiatry (01.03.2013)
Get more information
Journal Article
A phase III, double-blind, placebo-controlled, flexible-dose study of levomilnacipran extended-release in patients with major depressive disorder
Sambunaris, Angelo, Bose, Anjana, Gommoll, Carl P, Chen, Changzheng, Greenberg, William M, Sheehan, David V
Published in Journal of clinical psychopharmacology (01.02.2014)
Published in Journal of clinical psychopharmacology (01.02.2014)
Get more information
Journal Article
Efficacy of levomilnacipran extended-release in improving functional impairment associated with major depressive disorder: pooled analyses of five double-blind, placebo-controlled trials
Sambunaris, Angelo, Gommoll, Carl, Chen, Changzheng, Greenberg, William M
Published in International clinical psychopharmacology (01.07.2014)
Published in International clinical psychopharmacology (01.07.2014)
Get more information
Journal Article
Paliperidone Palmitate for Schizoaffective Disorder: A Review of the Clinical Evidence
Get full text
Journal Article
Book Review
Evaluation of Cytochrome P450 (CYP) 3A4-Based Interactions of Levomilnacipran with Ketoconazole, Carbamazepine or Alprazolam in Healthy Subjects
Chen, Laishun, Boinpally, Ramesh, Gad, Nayra, Greenberg, William M., Wangsa, Julie, Periclou, Antonia, Ghahramani, Parviz
Published in Clinical drug investigation (01.10.2015)
Published in Clinical drug investigation (01.10.2015)
Get full text
Journal Article
Effect of Hepatic Impairment on the Pharmacokinetics of Levomilnacipran Following a Single Oral Dose of a Levomilnacipran Extended-Release Capsule in Human Participants
Chen, Laishun, Boinpally, Ramesh, Greenberg, William M., Wangsa, Julie, Periclou, Antonia, Ghahramani, Parviz
Published in Clinical drug investigation (01.05.2014)
Published in Clinical drug investigation (01.05.2014)
Get full text
Journal Article
A randomized, double-blind, placebo-controlled study of flexible doses of levomilnacipran ER (40-120 mg/day) in patients with major depressive disorder
Gommoll, Carl P., Greenberg, William M., Chen, Changzheng
Published in Journal of drug assessment (London, U.K.) (01.01.2014)
Published in Journal of drug assessment (London, U.K.) (01.01.2014)
Get full text
Journal Article
A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Levomilnacipran ER 40-120mg/day for Prevention of Relapse in Patients with Major Depressive Disorder
Shiovitz, Thomas, Greenberg, William M, Chen, Changzheng, Forero, Giovanna, Gommoll, Carl P
Published in Innovations in clinical neuroscience (01.01.2014)
Get full text
Published in Innovations in clinical neuroscience (01.01.2014)
Journal Article
Effect of renal impairment on the pharmacokinetics of levomilnacipran following a single oral dose of levomilnacipran extended-release capsule in humans
Chen, Laishun, Greenberg, William M, Brand-Schieber, Elimor, Wangsa, Julie, Periclou, Antonia, Ghahramani, Parviz
Published in Drug design, development and therapy (01.01.2015)
Published in Drug design, development and therapy (01.01.2015)
Get full text
Journal Article